- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05487222
Goal Directed and Liberal Fluid Therapy
Goal Directed Fluid Therapy Compared to Liberal Fluid Therapy in Patients Subjected to Colorectal Surgery
Study Overview
Detailed Description
Intraoperative fluid management for major abdominal and intestinal surgeries is quite important in terms of postoperative organ perfusion and complications. Many complications such as acute renal failure, hypotension, arrhythmia, and anastomosis leak may occur secondary to intraoperative hypovolemia whereas hypervolemia may cause pulmonary edema, postoperative pneumonia, prolonged mechanical ventilation, delayed wound healing, edema in the gastrointestinal system (GIS), and decreased GIS motility.
In the perioperative period, fluid therapy and gastrointestinal function may complement each other or complicate it. If fluid therapy is not optimal, it may cause delayed gastrointestinal function and avoid early oral intake. If gastrointestinal dysfunction develops in the perioperative period, it may lead to fluid and electrolyte loss and metabolic problems. Thus, the intraoperative fluid management of the patient is very important.
Accurate assessment of a patient's volume status is an important goal for the anesthetist in the operating theatre to achieve hemodynamic stability and adequate tissue oxygenation. Different intraoperative fluid management protocols are in use for this purpose. The most common one is conventional fluid management (CFM). Fluid replacement is managed according to clinical assessment and heart rate (HR), arterial blood pressure (ABP) and central venous pressure (CVP) monitorization.
While goal-directed fluid therapy (GDFT) is a perioperative strategy, where fluid administration targets continuously-measured hemodynamic variables, such as cardiac output, stroke volume, stroke volume variation, pulse pressure variation and other factors to guide intravenous and inotropic therapy, with the aim of maximizing tissue perfusion and oxygen delivery.
Cardiac output is assessed by static indices or dynamic indices. Static indices of cardiac preload such as central venous pressure (CVP) and pulmonary artery wedge pressure are of little help for decisions regarding volume replacement. Dynamic variables such as pulse pressure variation (PPV) and stroke volume variation (SVV) are increasingly used to detect the cyclic fluctuation of the arterial pressure wave in the mechanically ventilated patient in order to predict fluid responsiveness.
Direct measurement of SV using noninvasive techniques has become an accepted tool for stroke volume optimization and guiding fluid administration in highly risk surgical patients. Many technologies are used to measure stroke volume, including Doppler monitoring, bio impedance/reactance measurements, and arterial waveform analysis. So, when stroke volume optimization is used as the end point, it could improve the outcomes for surgical patients with good prediction of fluid administration.
Impedance cardiography (ICG) is an accurate technique for noninvasive determination of hemodynamic variables such as stroke volume (SV), stroke volume index (SVI), cardiac output (COP), cardiac index (CI), systemic vascular resistance (SVR), and systolic time ratio (STR). ICG use electrical impedance changes to generate waveform that depend on volume and velocity of blood injected into aorta as well as the force and rate of left ventricle contraction. From that curve beside heart rate and blood pressure, stroke volume ,COP ,SVR and other hemodynamic parameter are derived
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Eldakahlia
-
Mansoura, Eldakahlia, Egypt
- Mansoura oncology center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• patients scheduled for elective colorectal surgery
- with (ASA) physical status I - II - of both gender aged 18-60 years old
- Hb >12 g/dl & Hct >38%.
Exclusion Criteria:
• Patient refusal
- Patients with major cardiovascular problems with ejection fraction < 40 %
- Renal impairment with serum creatinine >1.8 mg/dl .
- Patients with hepatic dysfunction and coagulopathy.
- Metabolic disorder, serum lactate > 4 mmol/L.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
• Liberal fluid group (L group) using traditional technique of fluid administration
|
hemodynamics variability in response to different fluid regiemens
|
|
• Goal directed fluid group(G group) using stroke volume optimization
|
hemodynamics variability in response to different fluid regiemens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
serum creatinine level
Time Frame: 24 hours postoperative
|
mg/dl
|
24 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
stroke volume (SV)
Time Frame: Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
|
|
stroke volume variation (SVV)
Time Frame: Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
percentage
|
Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
|
stroke volume index (SVI)
Time Frame: Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
ml/m2
|
Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
|
cardiac index
Time Frame: Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
L/minute/m2
|
Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
|
cardiac output (COP)
Time Frame: Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
L/minute
|
Basal preoperative, before induction of anesthesia (T1), just before skin incision (T2), then every 30 min until end of surgery then every 6 hour for 24 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R.19.12.704
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Therapy
-
Nordsjaellands HospitalRigshospitalet, Denmark; University of CopenhagenRecruitingFluid Therapy | Fluid Overload | Fluid AccumulationSpain, Denmark, India, United Kingdom, Finland, Iceland, Lithuania, New Zealand, Norway, Sweden, Switzerland
-
Centre Hospitalier Universitaire, AmiensCompletedFluid Therapy | Pharmacodynamics | Fluid Responsiveness | Fluid Challenge | Intravenous FluidsFrance
-
Uppsala UniversityCompletedFluid Therapy | Fluid Overload | Critical CareSweden
-
Erasme University HospitalUnknownFluid Therapy | Fluid and Electrolyte ImbalanceBelgium
-
Assiut UniversityCompleted
-
University of MonastirEnrolling by invitationFluid Therapy | Fluid Resuscitation | Fluid ReponsivenessTunisia
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Sociedad Española de Anestesiología, Reanimación...Hospital Clinic of Barcelona; Hospital Universitario La Fe; Hospital Universitario... and other collaboratorsUnknown
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalWithdrawnHemodynamic Monitoring | Fluid Management | Goal-Directed Fluid TherapyTurkey
-
Beijing Anzhen HospitalNot yet recruitingFluid Therapy | Microcirculation
Clinical Trials on ICON
-
Michigan State UniversityUnited States Department of Agriculture (USDA)Completed
-
Cynosure, Inc.CompletedScars | Wrinkles | Skin Laxity | Pigmentation | Stretch MarksUnited States
-
Universidade Federal de Santa MariaUnknownTooth; Lesion, White Spot LesionsBrazil
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Post Traumatic ArthritisUnited Kingdom, Netherlands, Canada, Germany
-
Cynosure, Inc.CompletedBenign Pigmented Lesions | Wrinkle | Benign Vascular LesionsUnited States
-
Assiut UniversityNot yet recruitingValue of Non Invasive Hemodynamic Monitoring in Patients Admitted to Respiratory Intensive Care UnitNon-invasive Hemodynamic Monitoring
-
National Research Centre, EgyptCompletedWhite Spot Lesion of ToothEgypt
-
King Abdullah University HospitalRecruiting
-
University of MichiganDMG Dental Material Gesellschaft mbHCompleted
-
Fisher and Paykel HealthcareHelios Klinik AmbrockCompletedSleep Apnea, ObstructiveGermany